Tyrosine kinase inhibitors enhanced the efficacy of conventional chemotherapeutic agent in multidrug resistant cancer cells.
Tyrosine kinase inhibitors enhanced the efficacy of conventional chemotherapeutic agent in multidrug resistant cancer cells.
复制标题
酪氨酸激酶抑制剂增强了传统化疗药物对多重耐药癌细胞的疗效。
DOI:
10.1186/s12943-018-0775-3
复制
发表时间:
2018-02-19
期刊:
影响因子:
37.3
通讯作者:
Fu L
中科院分区:
文献类型:
--
作者:
Wu S;Fu L
Multidrug resistance (MDR) triggered by ATP binding cassette (ABC) transporter such as ABCB1, ABCC1, ABCG2 limited successful cancer chemotherapy. Unfortunately, no commercial available MDR modulator approved by FDA was used in clinic. Tyrosine kinase inhibitors (TKIs) have been administrated to fight against cancer for decades. Almost TKI was used alone in clinic. However, drug combinations acting synergistically to kill cancer cells have become increasingly important in cancer chemotherapy as an approach for the recurrent resistant disease. Here, we summarize the effect of TKIs on enhancing the efficacy of conventional chemotherapeutic drug in ABC transporter-mediated MDR cancer cells, which encourage to further discuss and study in clinic.
登录
查看更多内容
影响因子:
11.2
作者:
Dai CL;Tiwari AK;Wu CP;Su XD;Wang SR;Liu DG;Ashby CR Jr;Huang Y;Robey RW;Liang YJ;Chen LM;Shi CJ;Ambudkar SV;Chen ZS;Fu LW
通讯作者:
Fu LW
DOI:
10.1007/978-1-60761-416-6_15
发表时间:
2010-01-01
期刊:
MULTI-DRUG RESISTANCE IN CANCER
影响因子:
--
作者:
Coley, Helen M.
通讯作者:
Coley, Helen M.
DOI:
10.2147/dddt.s89114
发表时间:
2016
期刊:
Drug design, development and therapy
影响因子:
--
作者:
Abbaspour Babaei M;Kamalidehghan B;Saleem M;Huri HZ;Ahmadipour F
通讯作者:
Ahmadipour F
DOI:
10.1016/j.apsb.2014.02.003
发表时间:
2014-06
期刊:
Acta pharmaceutica Sinica. B
影响因子:
--
作者:
Anreddy N;Patel A;Sodani K;Kathawala RJ;Chen EP;Wurpel JN;Chen ZS
通讯作者:
Chen ZS
影响因子:
--
作者:
Che, Huan-yong;Guo, Hang-yuan;Lou, Wei-ying
通讯作者:
Lou, Wei-ying